Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1211-1220 of 1,873) with videos related to

Pageof 188
Sort By:
Journal of the American Heart Association|May 2, 2022
Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC-NCSFrancesco Bianco, Raffaele De Caterina, Alvin Chandra, et al.
The New England Journal of Medicine|September 3, 2009
Cardiac-resynchronization therapy for the prevention of heart-failure eventsArthur J Moss, W Jackson Hall, David S Cannom, et al.
European Stroke Journal|April 23, 2019
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANTAzmil H Abdul-Rahim, Kieran F Docherty, Hicham Skali, et al.
Circulation|June 22, 2005
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarctionScott D Solomon, Hicham Skali, Nagesh S Anavekar, et al.
Journal of the American College of Cardiology|October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery diseaseMichelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Circulation. Heart Failure|November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
European Journal of Heart Failure|June 8, 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trialAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term OutcomesElke Platz, Ross T Campbell, Brian Claggett, et al.
European Journal of Heart Failure|August 27, 2023
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVERJawad H Butt, Henri Lu, Toru Kondo, et al.
European Journal of Heart Failure|November 12, 2015
One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failureDouglas L Mann, Randall J Lee, Andrew J S Coats, et al.
Pageof 188

Showing results (1211-1220 of 1,873) with videos related to

Sort By:
Pageof 188
Journal of the American Heart Association|May 2, 2022
Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC-NCSFrancesco Bianco, Raffaele De Caterina, Alvin Chandra, et al.
The New England Journal of Medicine|September 3, 2009
Cardiac-resynchronization therapy for the prevention of heart-failure eventsArthur J Moss, W Jackson Hall, David S Cannom, et al.
European Stroke Journal|April 23, 2019
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANTAzmil H Abdul-Rahim, Kieran F Docherty, Hicham Skali, et al.
Circulation|June 22, 2005
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarctionScott D Solomon, Hicham Skali, Nagesh S Anavekar, et al.
Journal of the American College of Cardiology|October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery diseaseMichelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Circulation. Heart Failure|November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
European Journal of Heart Failure|June 8, 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trialAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term OutcomesElke Platz, Ross T Campbell, Brian Claggett, et al.
European Journal of Heart Failure|August 27, 2023
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVERJawad H Butt, Henri Lu, Toru Kondo, et al.
European Journal of Heart Failure|November 12, 2015
One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failureDouglas L Mann, Randall J Lee, Andrew J S Coats, et al.
Pageof 188